Publications (190)

2022

  1. Iridium-and Palladium-Based Catalysts in the Pharmaceutical Industry

    Catalysts, Vol. 12, Núm. 2

  2. Zn(ii) complexes with thiazolyl-hydrazones: structure, intermolecular interactions, photophysical properties, computational study and anticancer activity

    CrystEngComm

  3. Study of the anticancer potential of Cd complexes of selenazoyl-hydrazones and their sulfur isosters

    European Journal of Medicinal Chemistry, Vol. 238

  4. Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents

    European Journal of Medicinal Chemistry, Vol. 228

  5. Oxonitrogenated Derivatives of Eremophilans and Eudesmans: Antiproliferative and Anti-Trypanosoma cruzi Activity

    Molecules, Vol. 27, Núm. 10

  6. Koanolides B-D, new sesquiterpene lactones from Koanophyllon gibbosum

    Phytochemistry Letters, Vol. 47, pp. 63-66

  7. Evaluation of anti-bacterial activity of novel 2, 3-diaminoquinoxaline derivatives: design, synthesis, biological screening, and molecular modeling studies

    Egyptian Journal of Basic and Applied Sciences, Vol. 9, Núm. 1, pp. 162-179

  8. Chemoselective Preparation of New Families of Phenolic-Organoselenium Hybrids—A Biological Assessment

    Molecules, Vol. 27, Núm. 4

  9. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease

    Bioorganic Chemistry, Vol. 127

  10. Alkaloid Profiling, Anti-Enzymatic and Antiproliferative Activity of the Endemic Chilean Amaryllidaceae Phycella cyrtanthoides

    Metabolites, Vol. 12, Núm. 2

  11. A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors

    Frontiers in Pharmacology, Vol. 13

  12. 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 37, Núm. 1, pp. 168-177